We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Temporary measures for COVID-19 and flu vaccine programme to be extended or made permanent through new consultation.
First published during the 2019 to 2022 Johnson Conservative government
This monoclonal antibody – the second to be authorised by the Medicines and Healthcare products Regulatory Agency – is for people with mild to moderate COVID-19 who are at high risk of developing severe disease.
As a precaution, companies are recalling some batches of irbesartan medicines due to presence of a chemical substance (AZBT) in an amount over the limit permitted for this product. Patients taking irbesartan medicines should…
Facebook, Instagram and TikTok boost support for vaccine programme
16 leading health charities partner with government and NHS to boost vaccine uptake amongst the country’s most vulnerable
Independent review will look at potential bias in items like oxygen measuring devices and the impact on patients from different ethnic groups.
Our safety monitoring to date shows that COVID-19 vaccines continue to have a positive safety profile for the majority of people.
The labelling states an incorrect maximum daily dose for 12-15-year olds. The MHRA, who issued the recall, says that that the risk to patients is very low.
The antiviral was found to be safe and effective following a stringent review of the available evidence.
Dr Laura Squire OBE has begun her role as the Medicines and Healthcare products Regulatory Agency’s (MHRA) Chief Healthcare Quality and Access Officer
Government action to cut the cost of repeatable HRT prescriptions and a new Menopause Taskforce means women experiencing the menopause will be better supported.
England could be the first country in the world to prescribe medicinally licensed e-cigarettes to help reduce smoking rates.
These principles are intended to lay the foundation for developing good machine learning practices (GMLP) and will help guide future growth in this rapidly progressing field.
National advertising campaign steps up today to encourage people to protect themselves and loved ones from COVID and flu this winter.
The new antivirals could be rolled out through a clinical study from winter.
People are being encouraged to contribute their views on changes to how medical devices will be regulated across the UK.
Tesco Max All-In-One Chesty Cough & Cold Lemon Sachets used for the relief of cold and flu symptoms is being recalled
AWTTC joins the Innovative Licensing and Access Pathway as a permanent partner
UK and the Republic of Korea will share over 1 million COVID-19 vaccine doses with each other to enhance rollout of life-saving jabs.
Ministers are announcing action to prevent medicines being prescribed unnecessarily, following a new review led by the Chief Pharmaceutical Officer for England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).